GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CES1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARA, PTGES, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
8.28253 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, MMP2, MMP9, PPARA, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
7.504 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TYR, XDH |
7.48344 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
7.48344 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, PIM1, PPARA, RELA, RORC, SRC |
7.48344 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGES, RELA, SRC, TERT |
7.38058 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADRA2A, AKR1B1, APP, AR, BCL2, CDC25B, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MMP12, MMP2, MMP9, PIM1, PTGES, RELA, SLC6A4, SRC, TERT, XDH |
7.38058 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, HSD17B2, HSD17B3 |
7.31491 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, PPARA, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
7.17429 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FUT7, HSD17B3, PIM1, PPARA, PTGES, TYR, XDH |
7.05112 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TYR, XDH |
7.05112 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CACNA1C, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSD17B3, KDR, MAP2K1, PPARA, RELA, SRC, TYR |
6.87908 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
6.82723 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APP, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, FABP3, FABP4, FUT7, HSD17B2, HSD17B3, MET, PPARA, PTGES |
6.82723 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, RELA, RORC, SLC6A4, SRC, TERT |
6.82723 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
6.82723 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, F10, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SRC, TERT, XDH |
6.7772 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, F10, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SRC, TERT, XDH |
6.75862 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F10, F3, FABP4, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RELA, RORC, SLC6A2, SLC6A4, SRC, TYR |
6.74283 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.60029 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, ESR1, F10, F3, FABP3, FABP4, FLT3, HSD17B2, HSD17B3, KCNH2, KDR, MAOA, MET, PPARA, SLC6A2, SLC6A4, SRC, TERT, XDH |
6.48682 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CYP1B1, F10, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, XDH |
5.95119 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APP, AR, BCL2, CA2, CYP1A2, ESR1, ESRRA, FABP3, FLT3, IGF1R, MMP2, PPARA, RELA, SLC6A4, SRC |
5.92171 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
5.92171 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADRA2A, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CES1, CHRM2, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
5.8455 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, AR, BCL2, CA2, CYP1A2, ESR1, ESRRA, FABP3, FLT3, PPARA, RELA, SLC6A4, SRC |
5.75433 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MMP2, MMP9, PTPN1, RELA, RORC, SLC6A4, SRC, TERT |
5.63573 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CACNA1C, CDC25B, CES1, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD17B2, HSD17B3, KDR, MAP2K1, MET, MMP2, MMP9, PIM1, PPARA, RELA, RORC, SLC6A4, SRC, TERT, TYR |
5.60507 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.42982 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, RELA, RORC, SLC6A4, SRC |
5.3603 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CYP1B1, F10, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SRC, TERT, XDH |
5.34683 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
5.2467 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
5.18781 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
5.07984 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, BCL2, CDC25B, ESR1, F3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, RELA, TERT |
5.00246 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.9787 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
4.84985 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TERT, XDH |
4.83086 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F10, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SRC, XDH |
4.77205 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SRC, TERT, TYR, XDH |
4.75954 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CYP1B1, ESRRA, F10, F3, FABP4, FLT3, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PTPN1, RELA, SRC, TERT, XDH |
4.74384 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA, PTGES |
4.74347 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SRC, TERT, TYR, XDH |
4.70286 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
4.70286 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PTPN1, RELA, SRC, TERT, XDH |
4.70286 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2, HSD17B3 |
4.6063 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CES1, CYP1A1, CYP1B1, KDR, RELA, SLC6A4, SRC |
4.56087 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.56087 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSD17B3, KDR, MAP2K1, MMP9, PIM1, PPARA, RELA, RORC, SRC, TYR |
4.56087 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
4.47937 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, HSD17B3, MAOA, TYR |
4.46227 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.40753 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.34686 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2, HSD17B3 |
4.26316 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
4.20911 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, ESR1, FLT3, RORC, SLC6A4, SRC |
4.17291 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MAP2K1, MMP9, PIM1, PTPN1, RELA, SRC, TERT, XDH |
4.14479 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, MAP2K1, SRC |
4.12583 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD17B2, HSD17B3, MAP2K1, MMP2, MMP9, SLC6A4, SRC |
4.11938 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
4.09076 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, APP, AR, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, RELA, SRC, TERT |
4.04577 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TERT |
3.99577 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.99577 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.99577 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADRA2A, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, F10, F3, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
3.98511 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRA2A, APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, XDH |
3.96696 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, FUT7, MET, PPARA, PTGES |
3.93949 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADRA2A, APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
3.93063 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADRA2A, APP, AR, AXL, BCL2, CA2, CACNA1C, CHRM2, CYP1B1, ESR1, ESRRA, ESRRB, F3, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, RELA, SLC6A4, SRC, TERT, XDH |
3.91644 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRA2A, APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
3.88294 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.88134 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, MAP2K1, SRC |
3.8766 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.81788 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, RELA, SRC, TERT |
3.74805 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRA2A, APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, XDH |
3.74805 |
[BP] GO:0080134 |
regulation of response to stress
|
ADRA2A, APP, CYP19A1, ESR1, F3, FABP4, IGF1R, MAP2K1, MAP3K7, MET, MMP12, MMP2, PPARA, PTPN1, RELA, SRC, TERT, XDH |
3.74805 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
3.74566 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, ESR1, IGF1R, MMP2, MMP9, RELA, RORC, SLC6A4, SRC |
3.68358 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
3.67982 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.6706 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGES, TERT |
3.66085 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADRA2A, APP, BCL2, CACNA1C, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.64636 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, FUT7, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.64636 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B2, HSD17B3, MAOA, TYR, XDH |
3.64403 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGES, RELA, SLC6A4, SRC |
3.64403 |
[BP] GO:0030334 |
regulation of cell migration
|
ADRA2A, APP, BCL2, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.59702 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, MAP2K1, MET, PIM1, SRC, TYR |
3.55608 |
[BP] GO:0042592 |
homeostatic process
|
ADRA2A, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, ESR1, FABP3, FABP4, FLT3, KCNH2, MET, SRC, TERT |
3.55043 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, RELA, SRC |
3.51865 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
3.51865 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
3.4797 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.45524 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
3.45524 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADRA2A, APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, F3, FLT3, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SRC, TERT, XDH |
3.39168 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRA2A, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
3.37508 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRA2A, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
3.37508 |
[BP] GO:2000145 |
regulation of cell motility
|
ADRA2A, APP, BCL2, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.3545 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.32731 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.30949 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.28819 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADRA2A, AR, BCL2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
3.26348 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADRA2A, AR, BCL2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
3.24948 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADRA2A, APP, AR, BCL2, CDC25B, ESRRB, FLT3, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
3.23253 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CYP1A1, CYP1A2, ESR1, F10, F3, FLT3, FUT7, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TYR, XDH |
3.23234 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA, PTGES |
3.21975 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, BCL2, IGF1R, KDR, MMP9, PIM1, PTPN1, RELA, SRC, TERT |
3.20716 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, RELA, SRC, TERT, XDH |
3.20665 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CYP1A1, CYP1B1, FABP3, KCNH2, KDR, RELA, SLC6A2, SLC6A4, SRC |
3.13117 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.09163 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADRA2A, APP, AR, BCL2, CDC25B, ESRRB, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
3.06441 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.05558 |
[BP] GO:0040012 |
regulation of locomotion
|
ADRA2A, APP, BCL2, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.03813 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MMP9, PTPN1, RELA, SRC, TERT |
3.02495 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADRA2A, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2, HSD17B3 |
3.02181 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADRA2A, APP, AR, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
3.01588 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.96116 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, ESR2, F10, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SRC, TERT, XDH |
2.95991 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, RELA, SRC |
2.94588 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRA2A, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
2.89264 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRA2A, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
2.84734 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.82146 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, ESR1, FABP3, FABP4, KCNH2, MET |
2.81054 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADRA2A, APP, AR, BCL2, CDC25B, FLT3, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
2.80351 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.77365 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, ESR1, FLT3, IGF1R, MMP2, RELA, SLC6A4, SRC |
2.73713 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SRC, TERT |
2.68391 |
[BP] GO:0007165 |
signal transduction
|
ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CACNA1C, CHRM2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SRC |
2.66209 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
2.65773 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
2.65773 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CACNA1C, CDC25B, CES1, CES2, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
2.62236 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.62 |
[BP] GO:0070920 |
None
|
ESR1, MAP2K1, TERT |
2.62 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.60007 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
2.60007 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
2.60007 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SRC, TERT |
2.60007 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADRA2A, AR, BCL2, CYP19A1, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, RELA, SRC, TERT, XDH |
2.60003 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, MMP2, PPARA, RELA, SLC6A4, SRC, TERT, TYR |
2.58428 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADRA2A, APP, AR, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.57766 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, BCL2, CDC25B, CES1, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, KDR, MAP2K1, MET, MMP2, MMP9, RORC, SRC, TERT |
2.57766 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, PTGES, TYR |
2.57419 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, ESR1, FLT3, RELA, RORC, SLC6A4, SRC |
2.57417 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADRA2A, APP, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, KCNH2, MAP2K1, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
2.57295 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, RELA, SRC, TERT |
2.56249 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
2.56249 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, AR, BCL2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, RELA, SRC, TERT, XDH |
2.50169 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.49036 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
2.48721 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MAP2K1, MET, MMP12, PPARA, PTPN1, RELA, RORC, SRC, TERT |
2.44642 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.44642 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.44642 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.44642 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADRA2A, APP, AR, BCL2, CDC25B, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
2.42087 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, PTGES, RELA, SRC |
2.41215 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, FABP3, FLT3, IGF1R, MMP2, PPARA, RELA, SLC6A4, SRC, TYR |
2.4005 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.39944 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, KCNH2, KDR, RELA, SRC |
2.37346 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
APP, AR, CYP1B1, ESR1, ESR2, MAP3K7, PIM1, RELA |
2.3679 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, ESR1, PPARA, RORC, SLC6A4, SRC |
2.36027 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
2.34187 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, SRC, XDH |
2.32229 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, IGF1R, KDR, PIM1, SRC |
2.32114 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, RELA |
2.30904 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SRC, TERT |
2.30904 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
2.30904 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, IGF1R, MET, MMP9, PTPN1, RELA, SRC, XDH |
2.30904 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.30673 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B2, HSD17B3 |
2.30673 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.3002 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.3002 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, KDR, MAP2K1, PIM1, RELA, SRC, TERT |
2.2825 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, PTGES, RELA, SRC |
2.2825 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MAOA |
2.26116 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADRA2A, APP, AR, BCL2, CDC25B, ESR1, F3, FLT3, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, RELA, SRC, XDH |
2.26116 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, PTGES, TYR |
2.25934 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25791 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.25791 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD17B2, HSD17B3 |
2.2433 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.22981 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.22981 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.22981 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, CACNA1C, KDR, SRC |
2.22981 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.21922 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21922 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADRA2A, APP, AXL, BCL2, CA2, CYP19A1, KCNH2, MMP12, SLC6A4, SRC, TERT |
2.21608 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, PTGES, TYR |
2.2125 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA |
2.2125 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.21145 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MAP3K7, MET, MMP2, MMP9, PTPN1, SRC |
2.21145 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, F10, F3, MET, SRC, XDH |
2.21145 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.2053 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PTPN1, RELA, SRC |
2.20373 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, FABP3, FLT3, IGF1R, MMP2, PPARA, RELA, SLC6A4, SRC, TYR |
2.19276 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.17334 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESR1, ESRRA, ESRRB, F3, KDR, MAP2K1, PIM1, PPARA, RELA, RORC, SLC6A4, SRC, TERT, XDH |
2.16566 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.16566 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HSD17B3 |
2.16222 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, SRC, XDH |
2.14509 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, RELA, SLC6A4, SRC, TYR |
2.13362 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AR, AURKB, AXL, BCL2, CDC25B, ESR1, F10, F3, FLT3, FUT7, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, SRC |
2.09938 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
APP, AR, BCL2, CYP1B1, FABP3, MAP2K1, PTGES, SLC6A4, TERT, XDH |
2.07906 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADRA2A, APP, AURKB, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
2.07659 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07659 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, ESR1, IGF1R, KDR, MAP2K1, MET, MMP1, MMP9, SRC |
2.05984 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, ESR1, HSD17B3 |
2.05977 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.05977 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.05977 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.05977 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESR1, ESRRA, F3, KDR, MAP2K1, PIM1, RELA, SLC6A4, SRC, TERT, XDH |
2.05055 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC |
2.05055 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADRA2A, APP, AR, BCL2, CDC25B, ESR1, F3, FLT3, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
2.03945 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CYP1A1, MAP2K1, RELA, TERT |
2.03838 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.03109 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.45066 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, F10, FLT3, HSD17B2, HSD17B3, PTGES, PTPN1 |
2.67612 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AR, AURKB, BCL2, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CES1, CES2, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, HSD17B2, HSD17B3, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, SLC6A4, SRC, TERT, TYR, XDH |
2.53626 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.39416 |
[CC] GO:0016020 |
membrane
|
ACHE, ADRA2A, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CACNA1C, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, F10, F3, FLT3, FUT7, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTGES, PTPN1, SLC6A2, SLC6A4, SRC, TERT, TYR |
2.2825 |
[CC] GO:0005783 |
None
|
APP, BCL2, CA4, CES1, CES2, CYP19A1, FLT3, HSD17B3, KDR, MAP2K1, PTPN1, XDH |
2.2825 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADRA2A, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, CHRM2, ESR1, F10, F3, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SRC, TERT |
2.2125 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
13.7691 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
9.48276 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
7.55769 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, F10, F3, FLT3, FUT7, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGES, PTPN1, SRC, TERT, TYR, XDH |
7.47777 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, MAP3K7, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
6.94162 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, MAP3K7, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
6.71425 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.71186 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.71186 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
6.26804 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.18415 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, RORC, SHBG |
5.16929 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.91881 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
4.68099 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B2, HSD17B3, MAOA, TYR, XDH |
4.51297 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.25706 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, PPARA, RORC, SHBG |
4.10307 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.99577 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
3.76453 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, BCL2, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MAP3K7, MET, MMP9, RELA, SLC6A4, TERT, TYR, XDH |
3.74805 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.68358 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.51678 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, RELA, SLC6A4, SRC |
3.49162 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PPARA, SLC6A4, SRC |
3.45066 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.45066 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.39168 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, SLC6A4, SRC |
3.23935 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.17751 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B2, HSD17B3, XDH |
3.0412 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.01992 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.01992 |
[MF] GO:0004871 |
signal transducer activity
|
ADRA2A, AR, AXL, CHRM2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PPARA, RORC |
2.96603 |
[MF] GO:0038023 |
signaling receptor activity
|
ADRA2A, AR, AXL, CHRM2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
2.95991 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.89264 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.82146 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
2.77365 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.7396 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2C19, ESR1, ESR2, ESRRB, F3, KCNH2, MET, PPARA, PTPN1, RELA, SLC6A4, SRC |
2.68489 |
[MF] GO:0008134 |
transcription factor binding
|
AR, BCL2, ESR1, ESRRB, FLT3, PIM1, PPARA, RELA, SRC, TERT |
2.57295 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES, SRC, XDH |
2.48114 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.47775 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.44642 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.44642 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.44491 |
[MF] GO:0004872 |
receptor activity
|
ADRA2A, AR, AXL, CHRM2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
2.42539 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.39416 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.3679 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.30904 |
[MF] GO:0060089 |
molecular transducer activity
|
ADRA2A, AR, AXL, CHRM2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
2.30211 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, BCL2, FLT3, KCNH2, RELA, SLC6A4, TERT, TYR, XDH |
2.2825 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.22981 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.22981 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TERT |
2.05977 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.05977 |
[MF] GO:0052689 |
carboxylic ester hydrolase activity
|
ACHE, CA1, CA2, CES1, CES2 |
2.05977 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.05897 |